The neuroprotective function of vascular endothelial growth factor (VEGF)

Folia Neuropathologica

Volumn 43, Issue 1, 2005, Pages 31-39

  Góra Kupilas, Kalina ^a   Jośko, Jadwiga ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Caspase 3; Neurogenesis; Neuroprotection; Programmed cell death; VEGFR 2 PI3K Akt signaling

Indexed keywords

ANTIOXIDANT; CASPASE 3; CASPASE 9; CELL CYCLE PROTEIN; CELL CYCLE PROTEIN 25; CYCLIN D1; CYCLIN E; GLUCOSE; HEME OXYGENASE 1; HEME OXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOPROTEIN; MESSENGER RNA; NEUROPROTECTIVE AGENT; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAD; PROTEIN KINASE B; TRANSCRIPTION FACTOR E2F; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ALTERNATIVE RNA SPLICING; ANGIOGENESIS; ANTIOXIDANT ACTIVITY; APOPTOSIS; BLOOD BRAIN BARRIER; BLOOD VESSEL PERMEABILITY; CELL HYPOXIA; CELL SURFACE; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; GLUCOSE TRANSPORT; NERVE CELL NECROSIS; NERVOUS SYSTEM DEVELOPMENT; NEUROPATHOLOGY; NEUROPHYSIOLOGY; NEUROPROTECTION; NEUROTROPISM; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 17344367099     PISSN: 16414640     EISSN: 1509572X     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Baek JH, Jang JE, Kang CM, Chung HY, Kim ND, Kim KW. Hypoxia-induced VEGF enhances tumor survivability via suppression of serum deprivation-induced apoptosis. Oncogene 2000; 19: 4621-4631.
2. Boyle PJ, Kempers SF, O'Connor AM, Nagy RJ. Brain glucose uptake and awareness of hypoglycemia in patients with insulin-dependent diabetes mellitus. N Egl J Med 1995; 333: 1726-1731.
3. Cao G, Luo Y, Nagayama T, Pei W, Stetler RA, Graham SH, Chen J. Cloning and characterization of rat caspase-9: implications for a role in mediating caspase-3 activation and hippocampal cell death after transient cerebral ischemia. J Cereb Blood Flow Metab 2002; 22: 534-546.
4. Cao G, Pei W, Lan J, Stetler RA, Luo Y, Nagayama T, Graham SH, Yin XM, Simon RP, Chen J. Caspase activated DNase/DNA fragmentation factor 40 mediates apoptotic DNA fragmentation in transient cerebral ischemia and in neuronal cultures. J Neurosci 2000; 21: 4678-4690.
5. Chen J, Nagayama T, Jin K, Stetler RA, Zhu RL, Graham SH, Simon RP. Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia. J Neurosci 1998; 18: 4914-4928.
6. Cisowski J. Wpływ stanu redoks komórki na aktywacje czynników transkrypcyjnych i ekspresje genów. Post Biol Kom 2001; 28: 43-59.
7. Dorle D, Bewersdorf J, Fruehwald-Schultes B, Kern W, Jelkmann W, Born J, Fehm HL, Peters A. Vascular endothelial growth factor: a novel endocrine defensive response to hypoglycemia. J Clin Endocrinol Metab 2002; 87: 835-840.
8. Dobrogowska DH, Lossinsky AS, Tarnawski AS, Tarnawski H, Vorbrodt AW. Increased blood-barrier permeability and endothelial abnormalities induced by vascular endothelial growth factor. J Neurocytol 1998: 27: 163-173.
9. Esser S, Wolburg K, Wolburg H, Breier G, Kurzchalia T, Risau W. Vascular endothelial growth factor induces endothelial fenestrations in vitro. J Cell Biol 1998; 140: 947-959.
10. Feng D, Nagy JK, Pyne K, Hammel I, Dvorak HF, Dvorak AM. Pathways of macromolecular extravasation across microvascular endothelium in resoonse to VPF/VEGF and other vasoactive mediators. Microcirculation 1999; 6: 23-44.
11. Ferrara N. Role of vascular endothelial growth factor in the regulation of angiogenesis. Kidney Int 2001; 56: 794-814.
12. Fischer S, Clauss M, Wiesnet M, Denz D, Schaper W. Karliczek GF. Hypoxia induces permeability in brain microvessel endothelial cells via VEGF and NO. Am J Physiol 1999; 276: C812-C820.
13. Forman LJ, Liu P, Nagete RG, Yin K, Wong PY. Augmentation of nitric oxide, superoxide, and peryoxynitrite production during cerebral ischemia and reperfusion in the rat. Neurochem Res 1998; 23: 141-148.
14. Gerber HP, Condorelli F, Park J, Ferrara N. Differential transcriptional regulation of the two vascular endothelial growth factor genes. Flt-1, but not Flk-1/kdr, is up-regulated by hypoxia. J Biol Chem 1997; 272: 23659-23667.
15. Gerich JE, Mokan M, Veneman T, Korytkowski M, Mitrakou A, Hypoglycemia unawareness. Endocr Rev 1991; 12: 356-371.
16. Graham SH, Chen J. Programmed cell death in cerebral ischemia. J Cereb Blood Flow Metab 2001; 21: 99-109.
17. Hayashi T, Sakurai M, Abe K, Sadahiro M, Tabayashi K, Itoyama Y. Expression of angiogenic factors in rabbit spinal cord after transient ischemia. Neuropathol Appl Neurobiol 1999; 25: 63-71.
18. Issa R, Krupiński J, Bujny T, Kumar S, Kaluza J, Kumar P. Vascular endothelial growth factor and its receptor KDR, in human brain tissue after ischemic stroke. Lab Invest 1999; 79: 417-425.
19. Jin K, Mao XO, Batteur SP, McEachron E, Leahy A, Greenberg DA. Caspase-3 and the regulation of hypoxic neuronal death by vascular endothelial growth factor. Neuroscience 2001; 108: 351-358.
20. Jin K, Mao XO, Greenberg DA. Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia. Proc Natl Acad Sci USA 2000; 97: 10242-10247.
21. Jin K, Minami M, Lan JO, Mao XO, Batteur S, Simon RP, Greenberg DA. Neurogenesis in dentate subgranular zone and rostral subventricular zone after focal cerebral ischemia in the rat. Proc Natl Acad Sci USA 2001; 98: 4710-4715.
22. Jin K, Nagayama T, Mao X, Kawaguchi K, Hickey RW, Greenberg DA, Simon RP, Graham SH. Two caspase-2 transcripts are expressed in rat hippocampus after global cerebral ischemia. J Neurochem 2002; 81: 25-35.
23. Jin K, Sun Y, Xie L, Peel A, Mao XO, Batteur S, Greenberg DA. Directed migration of neuronal precursors into the ischemic cerebral cortex and striatum. Mol Cell Neurosci 2003; 24: 171-189.
24. Jin K, Zhu Y, SunY, Mao XO, Xie L, Greenberg DA. Vascular endothelial growth factor stimulates neurogenesis in vitro and in vivo. Proc Natl Acad Sci USA 2002; 99: 11946-11950.
25. Jośko J. Cerebral angiogenesis and expression of VEGF after subarachnoid hemorrhage (SAH) in rats. Brain Res 2003; 981: 58-69.
26. Jośko J, Gwóźdź B, Jedrzejowska-Szyputka H, Hendryk S. Vascular endothelial growth factor (VEGF) and its effect on angiogenesis. Med Sci Monit 2000; 6: 1047-1052.
27. Jośko J, Gwóźdź B. The influence of hypoxia on blood vessels endothelial cell function in brain. Post Hig Med Dośw 2003; 57: 445-454.
28. Jośko J, Hendryk S, Jedrzejowska-Szypułka H, Słowiński J, Gwóźdź B, Jochem J. Expression of vascular endothelial growth factor (VEGF) in rat brain after subarachnoid hemorrhage and endothelin receptor blockage with BQ-123. Folia Neuropathol 2001; 4: 243-251.
29. Jośko J, Knefel K. The role of vascular endothelial growth factor in cerebral edema formation. Folia Neuropathol 2003; 3: 161-166.
30. Klagsbrun M, D'Amore P. Vascular endothelial growth factor and its receptors. Cytokine Growth Factor Rev 1996; 7: 259-270.
31. Kumagai AK, Kang YS, Boado RJ, Pardrige WM. Upregulation of blood-brain-barrier GLUT-1 glucose transporter protein and mRNA in experimental chronic hypoglycemia. Diabetes 1995; 44: 1399-1404.
32. Kuwano M, Fukushi J, Okamoto M, Nishie A, Goto H, Ishibashi T, Ono M. Angiogenesis factors. Intern Med 2001; 40: 565-572.
33. May MJ, Ghosh S. Signal transduction through NFκB. Immunol Today 1998; 2: 80-88.
34. Mayhan WG. VEGF increases permeability of the blood-brain -barrier via nitric oxide synthase/cGMP-dependent pathway. Am J Physiol 1999; 276: C1148-C1153.
35. Moeller JM, Rupec RA, Baeuerele PA. Study of gene regulation by NFκB and AP-1 in response to reactive oxygen intermediates. Methods 1997; 11: 301-312.
36. Motterlini R, Foresti R, Bassi R, Calabrese V, Clark JE, Green CJ. Endothelial heme oxygenase-1 induction by hypoxia. Modulation by inducible nitric-oxide synthase and S-nitrosothiols. J Biol Chem 2000; 275: 13613-13620.
37. Neufeld G, Tessler S, Gitay-Goren H, Cohen T, Levi BZ. Vascular endothelial growth factor and its receptors. Prog Growth Factor Res 1994; 5: 89-97.
38. Niki T, Iba S, Tokunou M, Yamada T, Matsuno Y, Hirohashi S. Expression of vascular endothelial growth factor A, B, C, D and their relationships to lymph node status in lung adenocarcinoma. Clin Cancer Res 2000; 6: 2431-2439.
39. Nishie A, Ono M, Shono T, Fukushi J, Otsubo M, Onoue H, Ito I, Inamura T, Ikezaki K, Fukui M, Iwaki T, Kuwano M. Macrophage infiltration and heme oxygenase-1 expression correlate with angiogenesis in human gliomas. Clin Cancer Res 1999; 5: 1107-1113.
40. N-Tsu K, Benhayon D, Przybylski RJ, Martin RJ, LaManna JC. Prolonged hypoxia increases vascular endothelial growth mRNA and protein in adult mouse brain. J Appl Physiol 1999; 86: 260-264.
41. Oosthuyse B, Moons L, Storkebaum E, Beck H, Nuyens D, Brusselmans K, Van-Dorpe J, Hellings P, Gorselink M, Heymans S, Theilmeier G, Dewerchin M, Laudenbach V, Vermylen P, Raat H, Acker T, Vleminckx V, Van-Den-Bosch L, Cashman N, Fujisawa H, Drost MR, Sciot R, Bruyninckx F, Hicklin DJ, Ince C, Gressens P, Lupu F, Plate KH, Robberecht W, Herbert JM, Collen D, Carmeliet P. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet 2001; 28: 131-138.
42. Parfenowa H, Neff RA, Alonso JS, Shlopov BV, Jamal CN, Sarkisova SA, Leffler CW. Cerebral vascular endothelial heme oxygenase: expression, localization, and activation by glutamate. Am J Physiol Cell Physiol 2001; 281: C1954-C1963.
43. Pekala P, Marlow M, Heuvelman D, Connoly D. Regulation of hexose transport in aortic endothelial cells by vasculary permeability factor and tumor necrosis factor alpha, but not by insulin. J Biol Chem 1990; 265: 18051-18054.
44. Petrova TV, Makinen T, Alitalo K. Signaling via vascular endothelial growth factor receptors. Exp Cell Res 1999; 253: 117-130.
45. Polte T, Abate A, Dennery PA, Schroder H. Heme oxygenase-1 is a cGMP-inducible endothelial protein and mediates the cytoprotective action of nitric oxide. Arterioscler Thromb Vasc Biol 2000; 20: 1209-1215.
46. Radisavljevic Z, Avraham S. Vascular endothelial growth factor up-regulates ICAM-1 expression via the phosphatidyloinositol 3 OH-kinase/AKT/Nitric oxide pathway and modulates migration of brain microvascular endothelial cells. J Biol Chem 2000; 275 (27): 20770-20774.
47. Ryter T, Abate A, Dennery PA, Schroder H. Regulation of endothelial heme oxygenase-1 activity during hypoxia is dependent on chelatable iron. Am J Physiol Heart Circ Physiol 2000; 279: H2889-H2897.
48. Shepherd PR, Kahn BB. Glucose transporters and insulin action-implications for insulin resistance and diabetes mellitus. N Engl J Med 1999; 341: 248-257.
49. Sone H, Deo BK, Kumagai AK. Enhacement of glucose transport by vascular endothelial growth factor in retinal endothelial cells. Invest Ophthalmol Vis Sci 2000; 41: 876-1884.
50. Sun Y, Jin K, Xie L, Childs J, Mao XO, Logvinova A, Greenberg DA. VEGF-induced neroprotection, neurogenesis and angiogenesis after focal cerebral ischemia, J Clin Invest 2003; 111: 1843-1851.
51. Volm M, Mattern J, Koomagi R. Inverse correlation between apoptotic (Fas ligand, caspase-3) and angiogenic factors (VEGF, microvessel density) in squamous cell lung carcinoma. Anticancer Res 1999; 19: 1669-1671.
52. Wang W, Dentler WL, Borchardt RT. VEGF increases BMEC monolayer permeability by affecting occluding expression and tight junction assembly. Heart Circ 2001; 280: H434-H440.
53. Weisz A, Koren B, Fischer L, Lewis BS, Fungelman MY. Therapeutic angiogenesis for ischemic syndrome. Isr Med Assoc J 2000; 2: 52-57.
54. Zhang ZG, Zhang LC, Davies K, Powers C, Bruggen N, Chopp M. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest 2000; 106: 829-839.
55. ZhuY, Jin K, Mao XO, Greenberg DA. Vascular endothelial growth factor promotes proliferation of cortical neuron precursors by regulating E2F expression. FASEB-J 2003; 17: 186-193.